Papers

1

Total Citations

57

H-Index

1

About

Cheong Hoon Kwon is a pioneering researcher in the field of biomedical microdevices, with a focus on developing accessible, high-throughput screening (HTS) platforms for drug discovery and cellular analysis. His most notable contribution is the creation of drug-eluting microarrays for cell-based screening, as demonstrated in his highly cited 2011 paper (57 citations), which introduced a simple, cost-effective alternative to traditional, equipment-intensive HTS systems. This work addresses a critical barrier in biomedical research by enabling broader access to screening technologies, particularly for studying chemical-induced apoptosis. Kwon’s innovations bridge materials science, microfluidics, and cell biology, offering scalable tools for drug testing and personalized medicine. His research has garnered significant attention, with his top-cited paper serving as a foundational reference for labs seeking to democratize high-throughput assays. By simplifying complex screening processes, Kwon empowers researchers without access to centralized facilities, accelerating discoveries in chemical biology and therapeutic development. His achievements underscore a commitment to making advanced biomedical tools more inclusive and impactful.

Research Focus

Key Achievements

1
H-Index
1
Papers
57
Total Citations
57
Avg Citations/Paper
🏆 Most Cited Paper
Drug-Eluting Microarrays for Cell-Based Screening of Chemical-Induced Apoptosis
57 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Harvard–MIT Division of Health Sciences and Technology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago